Early Diagnosis of Genetic Diseases

Parabase Genomics is a privately held molecular diagnostics company focused on changing the way newborns and children with genetic disorders are diagnosed and treated. The Company’s LifeTime Tests™ are the first commercially available services that provide a rapid non-invasive method for sample collection and diagnosis of genetic conditions using dried blood spots. This proprietary genetic and informational platform generates actionable information about a newborn’s disease profile. Physicians can now avoid delays associated with confirmatory, single gene, exome or genome testing by providing treatment options on time and mitigate adverse consequences by providing results while the patient is still in the hospital.

We are a team of innovators with expertise in genomics, pediatrics, and computational biology committed to improving the lives of children with genetic diseases.